MPC-1 levels at 3 months were significantly associated with clinical RF at 12 months (odds ratio, 2.89; 95% CI, 1.19-7.19), whereas baseline MPC-1 levels approached significance (odds ratio, 2.08; 95% CI, 0.99-4.30).
← all excerpts
Inflammatory Markers Associated With Radiation-Induced Lung Injury, Metastasis and Mortality After Breast Cancer Treatment.
1
—
—